期刊文献+

与卵巢癌转移有关的microRNA研究进展 被引量:1

Research of microRNA Related to Metastasis of Ovarian Cancer
原文传递
导出
摘要 卵巢癌是女性生殖系统三大恶性肿瘤之一,其致死率居于各类妇科肿瘤之首,是严重影响妇女生命的重要疾患,卵巢癌的转移则是造成病人死亡的重要因素。近年来随着microRNA(又称miRNA或微RNA)作为一种小分子非编码RNA被发现,证实miRNA的作用与各类肿瘤有着重要的联系,这些肿瘤包括乳腺癌、食管癌、胰癌、口腔癌等。近几年的研究表明,miRNA可以影响卵巢癌的发生与发展,并与其转移也存在着紧密的关系。与卵巢癌转移有关的miRNA作用机制的揭示,将会为转移性卵巢癌的诊断及治疗提供新的途径。本综述在通过检索近年来最新文献的基础上,对于卵巢癌的转移机理进行了详尽的分析,并对miRNA在卵巢癌转移中的重要研究予以了详细的阐述。 As one of the three major malignant tumors concerning the female reproductive system,ovarian cancer's lethality is the leading cause of death from gynecologic cancers.It severely affects women's lives.The metastasis of Ovarian cancer is an important factor in causing deaths.MicroRNA's(miRNA) are a recently discovered class of Small molecule and noncoding RNA's.There is a Sig-nificant relationship between microRNAs and various types of cancer,these tumors include breast cancer,esophageal cancer,pancreatic cancer,oral cancer,etc.In recent years,some studies have shown that miRNA could have a great influence on the occurrence and devel-opment of ovarian cancer,and also on the metastasis of Ovarian cancer.If miRNA mechanism was revealed to be related to the metas-tasis of ovarian cancer,it would provide a new approach to the diagnosis and treatment of metastatic ovarian cancer.Based on the latest literature,this review is a detailed analysis on the metastatic mechanism of ovarian cancer and the role of miRNA within it.
出处 《现代生物医学进展》 CAS 2011年第14期2793-2796,共4页 Progress in Modern Biomedicine
关键词 卵巢癌 肿瘤转移 MICRORNAS Ovarian neoplasms Neoplasm metastasis MicroRNAs
  • 相关文献

参考文献40

  • 1Lee RC, Feinbaum RL,Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell ,1993,75:843-854.
  • 2Lu J ,Gad G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature,2005,435:834-838.
  • 3Tsai NP, Lin YL,Wei LN. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIPI40) mRNA and up-regulates its protein expression[J]. Bioehem J,2009,424:411-418.
  • 4潘颖,王英坚,刘俊宝,方红娟,张桂珍.RhoC沉默抑制卵巢癌细胞的生长及转移[J].中国免疫学杂志,2009,25(5):425-429. 被引量:1
  • 5乔锋利,潘颖,王英坚,司乃文,林昱,梁雪,王辉.RhoC与MMP_2在卵巢癌侵袭与转移中的相互作用[J].中国实验诊断学,2009,13(7):919-923. 被引量:3
  • 6柳英兰,郑建华.HMGA1基因小分子RNAi对卵巢癌转移抑制的实验研究[J].现代肿瘤医学,2009,17(9):1629-1632. 被引量:1
  • 7王菁,黎丹戎,李力.integrin α6和MKK4基因在卵巢癌不同淋巴结转移能力细胞系中的表达及其意义[J].广西医科大学学报,2009,26(2):165-169. 被引量:5
  • 8Wiley A, Katsaros D, Chen H, et al. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential[J]. Cancer, 2006,107:299-308.
  • 9Murthi P, Barker G, Nowell C J, et al. Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression [J]. Gynecol Oncol, 2004,92:80-88.
  • 10Adley BP, Gleason KJ, Yang XJ, et al. Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma [J]. Gynecol Oncol, 2009,112:319-324.

二级参考文献62

共引文献10

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部